Chest
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
The Aging Lung: Is Lung Health Good Health for Older Adults?
2018
-
Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
153:1396-1404.
2018
-
Giants in Chest Medicine: Professor Emeritus Elizabeth F. Juniper, MCSP, MSc..
153:776-777.
2018
-
Stem Cells in Pulmonary Disease and Regeneration.
153:994-1003.
2018
-
Expiratory Flow Limitation During Mechanical Ventilation.
154:948-962.
2018
-
Crotalaria (Monocrotaline) Pulmonary Hypertension: The Fiftieth Anniversary..
152:1117-1119.
2017
-
Patient and Family Engagement in Designing and Implementing a Weaning Trial.
152:707-711.
2017
-
IV Immunoglobulin for Autoimmune Heparin-Induced Thrombocytopenia.
152:453-455.
2017
-
Hematopoietic Processes in Eosinophilic Asthma.
152:410-416.
2017
-
Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study..
152:81-91.
2017
-
The Magic Bullet in Sepsis or the Inflation of Chance Findings?.
152:222-223.
2017
-
Epithelial-Derived Cytokines in Asthma.
151:1338-1344.
2017
-
The Potential Role of Aspiration in the Asthmatic Airway.
151:1272-1278.
2017
-
An Update on Lymphocyte Subtypes in Asthma and Airway Disease.
151:1122-1130.
2017
-
Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants.
151:127-138.
2017
-
Liberation From Mechanical Ventilation in Critically Ill Adults.
151:160-165.
2017
-
Liberation From Mechanical Ventilation in Critically Ill Adults: An Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline.
151:166-180.
2017
-
POINT: Will New Anti-eosinophilic Drugs Be Useful in Asthma Management? Yes.
151:14-17.
2017
-
Rebuttal From Dr O’Byrne.
151:20-21.
2017
-
Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening Study.
150:1015-1022.
2016
-
Measuring Eosinophils to Make Treatment Decisions in Asthma.
150:485-487.
2016
-
Platelet Activation Testing for Heparin-Induced Thrombocytopenia Antibodies: A Problem That Needs Fixing?.
150:478-480.
2016
-
Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry..
150:516-523.
2016
-
Surfactant Protein-D and Asthma.
149:1121-1122.
2016
-
Interpretability of Change Scores in Measures of Balance in People With COPD.
149:696-703.
2016
-
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report..
149:315-352.
2016
-
Dosage in: Antiplatelet Drugs: Antithrombotic Therapy and Prevention of Thrombosis: 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (vol 141, pg e89S, 2012).
148:1529-1529.
2015
-
Timing the First Postoperative Dose of Anticoagulants: Lessons Learned From Clinical Trials..
148:587-595.
2015
-
The Role for Optical Density in Heparin-Induced Thrombocytopenia: A Cohort Study..
148:55-61.
2015
-
Physiologic Characterization of the Chronic Bronchitis Phenotype in GOLD Grade IB COPD.
147:1235-1245.
2015
-
Development of a Novel, Multilayered Presentation Format for Clinical Practice Guidelines.
147:754-763.
2015
-
Is quadriceps endurance reduced in COPD?: a systematic review..
147:673-684.
2015
-
The Effect of Omega-3 Fatty Acids on Bronchial Hyperresponsiveness, Sputum Eosinophilia, and Mast Cell Mediators in Asthma.
147:397-405.
2015
-
Spread the Word About CHEST in 2015: Rising Impact Factor, Continuous Innovations, and Changes to the Editorial Team..
147:1-3.
2015
-
Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process..
146:727-734.
2014
-
Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: results from the Norwegian adaptation of the Antithrombotic Therapy and the Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines..
146:735-761.
2014
-
New Approaches to TB Vaccination.
146:804-812.
2014
-
Risk of Mycobacterial Infections Associated With Rheumatoid Arthritis in Ontario, Canada.
146:563-572.
2014
-
A Man in His 40s With Fever and Hypotension.
145:e17-e19.
2014
-
Non-vitamin K antagonist oral anticoagulants: an appeal for consensus on terminology..
145:1177-1178.
2014
-
Response.
145:1174-1175.
2014
-
Measurement of Activities of Daily Living in Patients With COPD.
145:253-271.
2014
-
Trends in the Prevalence of Asthma.
145:219-225.
2014
-
A Randomized Controlled Trial of Balance Training During Pulmonary Rehabilitation for Individuals With COPD.
144:1803-1810.
2013
-
Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: a systematic review of clinical practice guidelines..
144:1848-1856.
2013
-
Response..
144:1979-1980.
2013
-
Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma.
144:1222-1229.
2013
-
Improving Clinical Interpretation of the Anti-Platelet Factor 4/Heparin Enzyme-Linked Immunosorbent Assay for the Diagnosis of Heparin-Induced Thrombocytopenia Through the Use of Receiver Operating Characteristic Analysis, Stratum-Specific Likelihood Ratios, and Bayes Theorem.
144:1269-1275.
2013
-
Interruption of Warfarin Anticoagulation for Dental Surgery: Response.
144:1424-1426.
2013
-
Low Anonymous Voting Compliance With the Novel Policy for Managing Conflicts of Interest Implemented in the 9th Version of the American College of Chest Physicians Antithrombotic Guidelines.
144:1111-1116.
2013
-
Systematic Review of Supervised Exercise Programs After Pulmonary Rehabilitation in Individuals With COPD.
144:1124-1133.
2013
-
Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis.
144:1207-1215.
2013
-
Heparin-Induced Thrombocytopenia in Medical Surgical Critical Illness.
144:848-858.
2013
-
Creating clinical practice guidelines we can trust, use, and share: a new era is imminent..
144:381-389.
2013
-
Creating clinical practice guidelines: problems and solutions..
144:365-367.
2013
-
Detection of COPD Exacerbations and Compliance With Patient-Reported Daily Symptom Diaries Using a Smartphone-Based Information System.
144:507-514.
2013
-
Experiences with a novel policy for managing conflicts of interest of guideline developers: a descriptive qualitative study..
144:398-404.
2013
-
Quality assessment of asthma clinical practice guidelines: a systematic appraisal..
144:390-397.
2013
-
The Occurrence and Impact of Bacterial Organisms Complicating Critical Care Illness Associated With 2009 Influenza A(H1N1) Infection.
144:39-47.
2013
-
Protein Misfolding and Endoplasmic Reticulum Stress in Chronic Lung Disease.
143:1098-1105.
2013
-
Response to Dr Junqueira..
143:1191.
2013
-
Are Asymptomatic DVTs Relevant? One Measure for All Response.
143:874-875.
2013
-
Asthma Associated With Incontinentia Pigmenti and Fanconi Anemia.
143:856-858.
2013
-
Response..
143:874-875.
2013
-
The Poorly Explored Impact of Uncontrolled Asthma.
143:511-523.
2013
-
The Influence of Cigarette Smoking on Viral Infections.
143:196-206.
2013
-
The Pros and Cons of Propensity Scores.
142:1380-1382.
2012
-
Clarification of Once-Daily Low-Molecular-Weight Heparin Dosing in Pulmonary Embolism: Response.
142:1075-1076.
2012
-
Heparin-induced thrombocytopenia in the ICU: a transatlantic perspective..
142:815-816.
2012
-
Role of Cystic Fibrosis Transmembrane Conductance Regulator in Patients With Chronic Sinopulmonary Disease.
142:996-1004.
2012
-
Angiogenesis in pulmonary fibrosis: too much or not enough?.
142:200-207.
2012
-
Preventing VTE in Outpatients With Cancer: Response.
142:266-267.
2012
-
Impairments in Systems Underlying Control of Balance in COPD.
141:1496-1503.
2012
-
Perioperative Management of Antithrombotic Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (vol 141, pg e326S, 2012).
141:1129-1129.
2012
-
Gene Expression Profiling in the Lungs of Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis.
141:661-673.
2012
-
Mine is bigger than yours: measures of effect size in research..
141:595-598.
2012
-
Antiplatelet Drugs.
141:e89S-e119S.
2012
-
Antithrombotic Therapy for Atrial Fibrillation.
141:e531S-e575S.
2012
-
Antithrombotic Therapy for VTE Disease.
141:e419S-e496S.
2012
-
Antithrombotic Therapy in Neonates and Children.
141:e737S-e801S.
2012
-
Antithrombotic Therapy in Peripheral Artery Disease.
141:e669S-e690S.
2012
-
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke.
141:e601S-e636S.
2012
-
Approach to Outcome Measurement in the Prevention of Thrombosis in Surgical and Medical Patients.
141:e185S-e194S.
2012
-
Diagnosis of DVT.
141:e351S-e418S.
2012
-
Evidence-Based Management of Anticoagulant Therapy.
141:e152S-e184S.
2012
-
Executive Summary.
141:7S-47S.
2012
-
Introduction to the Ninth Edition.
141:48S-52S.
2012
-
Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines.
141:53S-70S.
2012
-
New Antithrombotic Drugs.
141:e120S-e151S.
2012
-
Oral Anticoagulant Therapy.
141:e44S-e88S.
2012
-
Parenteral Anticoagulants.
141:e24S-e43S.
2012
-
Patient Values and Preferences in Decision Making for Antithrombotic Therapy: A Systematic Review.
141:e1S-e23S.
2012
-
Perioperative Management of Antithrombotic Therapy.
141:e326S-e350S.
2012
-
Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials..
141:308-320.
2012
-
Prevention of VTE in Nonsurgical Patients.
141:e195S-e226S.
2012
-
Prevention of VTE in Orthopedic Surgery Patients.
141:e278S-e325S.
2012
-
Primary and Secondary Prevention of Cardiovascular Disease.
141:e637S-e668S.
2012
-
Severe Bronchorrhea in a Patient with Bronchioloalveolar Carcinoma.
141:513-514.
2012
-
Treatment and Prevention of Heparin-Induced Thrombocytopenia.
141:e495S-e530S.
2012
-
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy.
141:e691S-e736S.
2012
-
Do CIs Give You Confidence?.
141:17-19.
2012
-
How should we measure arm exercise capacity in patients with COPD? A systematic review..
141:111-120.
2012
-
Serum Procalcitonin and Infective Exacerbations of Asthma.
140:1389-1390.
2011
-
Probiotics in United Airways Disease: Response.
140:1100-1101.
2011
-
Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE.
140:706-714.
2011
-
Dosing Frequency of Unfractionated Heparin Thromboprophylaxis.
140:374-381.
2011
-
Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE.
140:366-373.
2011
-
Correction for multiple testing: is there a resolution?.
140:16-18.
2011
-
Point: Is Measuring Sputum Eosinophils Useful in the Management of Severe Asthma? Yes.
139:1270-1273.
2011
-
Rebuttal From Drs Hargreave and Nair.
139:1275-1277.
2011
-
Assessing the Performance of the HAS-BLED Score Is the C Statistic Sufficient? Response.
139:1248-1248.
2011
-
More Rigor Needed in Systematic Reviews on “Waterpipe” (Hookah, Narghile, Shisha) Smoking: Response.
139:1251-1252.
2011
-
Simulator training for recognition of murmurs: give a kid a hammer?.
139:1257-1258.
2011
-
The HAS-BLED Score and Renal Failure: Response.
139:1249-1250.
2011
-
Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) (vol 133, pg 340S, 2008).
139:1261-1261.
2011
-
Effects of water-pipe smoking on lung function: a systematic review and meta-analysis..
139:764-774.
2011
-
Probiotics and Lung Diseases.
139:901-908.
2011
-
Nontubercular Mycobacterial Pulmonary Infection in Severe Asthma.
139:721-721.
2011
-
Comparison of the Effect of Low-Dose Ciclesonide and Fixed-Dose Fluticasone Propionate and Salmeterol Combination on Long-term Asthma Control.
139:311-318.
2011
-
The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review..
139:271-278.
2011
-
Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators..
139:69-79.
2011
-
Resistance arm training in patients with COPD: A Randomized Controlled Trial..
139:151-158.
2011
-
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation.
138:1093-1100.
2010
-
CHA(2)DS(2)-VASc Risk Scheme Not Ready for Clinical Use Response.
138:1020-1021.
2010
-
Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis..
138:840-847.
2010
-
Conclusion.
138:44S-45S.
2010
-
Introduction.
138:1S-3S.
2010
-
Measuring Bronchitis in Airway Diseases: Clinical Implementation and Application.
138:38S-43S.
2010
-
Obstructive Sleep Apnea Is a Risk Factor for Stroke and Atrial Fibrillation: Response.
138:239-240.
2010
-
Recent Advances in the Pathophysiology of Asthma.
137:1417-1426.
2010
-
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation..
137:263-272.
2010
-
Deep Vein Thrombosis Prophylaxis: Response.
136:1700-1701.
2009
-
Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism.
136:1537-1545.
2009
-
The Effects of Inhaled Budesonide on Lung Function in Smokers and Nonsmokers With Mild Persistent Asthma.
136:1514-1520.
2009
-
Changes in Exhaled Nitric Oxide Related to Estrogen and Progesterone During the Menstrual Cycle.
136:1301-1307.
2009
-
Medical Questionnaires Are Copyrighted To Ensure That Validity Is Maintained.
136:951-952.
2009
-
Safety of long-acting beta-agonists: are new data really required?.
136:604-607.
2009
-
Antiinflammatory effects of long-acting beta2-agonists in patients with asthma: a systematic review and metaanalysis..
136:145-154.
2009
-
Balancing the Risks and Benefits of Thromboprophylaxis in Patients Undergoing Podiatric Surgery.
135:888-890.
2009
-
The American College of Chest Physicians evidence-based educational guidelines for continuing medical education interventions: a critical review of evidence-based educational guidelines..
135:834-837.
2009
-
Variations and Gaps in Management of Acute Asthma in Ontario Emergency Departments.
135:724-736.
2009
-
American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?.
135:513-520.
2009
-
The Need for Expertise and the Scientific Base of Evidence-Based Medicine: Response.
135:245-246.
2009
-
Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled β 2 -Agonists in Achieving Asthma Control.
134:1192-1199.
2008
-
Eosinophil progenitors in airway diseases: clinical implications..
134:1037-1043.
2008
-
Alendronate Once Weekly for the Prevention and Treatment of Bone Loss in Canadian Adult Cystic Fibrosis Patients (CFOS Trial).
134:794-800.
2008
-
Rapid effect of inhaled ciclesonide in asthma: a randomized, placebo-controlled study..
134:740-745.
2008
-
Asthma Management by Monitoring Sputum Neutrophil Count.
134:628-630.
2008
-
Antithrombotic and thrombolytic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (vol 133, pg 110S, 2008).
134:473-473.
2008
-
Grades of recommendation for antithrombotic agents (vol 133, pg 123S, 2008).
134:473-473.
2008
-
Methodology of antithrombotic and thrombolytic therapy guideline development (vol 133, pg 133S, 2008).
134:473-473.
2008
-
New antithrombotic drugs (vol 133, pg 234S, 2008).
134:473-473.
2008
-
Parenteral anticoagulants: American college of chest physicians evidence-based clinical practice guidelines (8th edition) (vol 133, pg 141S, 2008).
134:474-474.
2008
-
What Is the Burden of Chronic Cough for Families?.
134:303-309.
2008
-
Antiplatelet Drugs.
133:199S-233S.
2008
-
Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes.
133:670S-707S.
2008
-
Antithrombotic Therapy for Venous Thromboembolic Disease.
133:454S-545S.
2008
-
Antithrombotic Therapy in Neonates and Children.
133:887S-968S.
2008
-
Antithrombotic and Thrombolytic Therapy.
133:110S-112S.
2008
-
Executive Summary.
133:71S-109S.
2008
-
Grades of Recommendation for Antithrombotic Agents.
133:123S-131S.
2008
-
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment.
133:257S-298S.
2008
-
Methodology for Antithrombotic and Thrombolytic Therapy Guideline Development.
133:113S-122S.
2008
-
New Antithrombotic Drugs.
133:234S-256S.
2008
-
Parenteral Anticoagulants.
133:141S-159S.
2008
-
Pharmacology and Management of the Vitamin K Antagonists.
133:160S-198S.
2008
-
Reflecting on Eight Editions of the American College of Chest Physicians Antithrombotic Guidelines.
133:1293-1295.
2008
-
The Perioperative Management of Antithrombotic Therapy.
133:299S-339S.
2008
-
The Primary and Secondary Prevention of Coronary Artery Disease.
133:776S-814S.
2008
-
Treatment and Prevention of Heparin-Induced Thrombocytopenia.
133:340S-380S.
2008
-
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy.
133:844S-886S.
2008
-
Long-Acting Bronchodilators in COPD.
133:1057-1058.
2008
-
Point: Evidence-Based Medicine Has a Sound Scientific Base.
133:1067-1071.
2008
-
Rebuttal From Dr. Guyatt et al.
133:1074-1075.
2008
-
Development of a Parent-Proxy Quality-of-Life Chronic Cough-Specific Questionnaire.
133:386-395.
2008
-
Sputum Eosinophils and the Response of Exercise-Induced Bronchoconstriction to Corticosteroid in Asthma.
133:404-411.
2008
-
Regulatory T Cells in Allergy and Asthma.
132:1007-1014.
2007
-
Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism..
132:936-945.
2007
-
Contrast Echocardiography Grading Predicts Pulmonary Arteriovenous Malformations on CT.
132:18-23.
2007
-
High-Frequency Oscillatory Ventilation for Adult Patients With ARDS.
131:1907-1916.
2007
-
Who Is (Still) Getting HIT?.
131:1620-1622.
2007
-
Risk of Thrombosis With Lenalidomide and Its Prevention With Aspirin.
131:275-277.
2007
-
Morbidity and Mortality of Patients With Invasive Group A Streptococcal Infections Admitted to the ICU.
130:1679-1686.
2006
-
Gene Therapy for Pulmonary Diseases.
130:879-884.
2006
-
Montelukast Treatment Attenuates the Increase in Myofibroblasts Following Low-Dose Allergen Challenge.
130:741-753.
2006
-
The Salmeterol Multicenter Asthma Research Trial.
130:928-928.
2006
-
Think of HIT When Thrombosis Follows Heparin.
130:631-632.
2006
-
Resource allocation issues and clinical practice guidelines..
130:623.
2006
-
Understanding cardiopulmonary resuscitation decision making - Perspectives of seriously ill hospitalized patients and family members.
130:419-428.
2006
-
Cytokines or Their Antagonists for the Treatment of Asthma.
130:244-250.
2006
-
Effects of Early Intervention With Inhaled Budesonide on Lung Function in Newly Diagnosed Asthma.
129:1478-1485.
2006
-
Aerosol delivery devices.
129:1389-1389.
2006
-
Impact of Pulmonary Rehabilitation on Psychosocial Morbidity in Patients With Severe COPD.
129:899-904.
2006
-
Intensive care and emergency medicine: progress over the past 25 years..
129:1061-1067.
2006
-
Pulmonary Function and Abdominal Adiposity in the General Population.
129:853-862.
2006
-
The Ontario asthma regional variation study - Emergency department visit rates and the relation to hospitalization rates.
129:909-917.
2006
-
Treatment strategy for asthma: one for all and all for one?.
129:221-223.
2006
-
Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force..
129:182-187.
2006
-
Beta2 déjà vu..
129:3-5.
2006
-
Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force..
129:174-181.
2006
-
Role of Angiopoietin-1 in Experimental and Human Pulmonary Arterial Hypertension.
128:633S-642S.
2005
-
Five-Day Telithromycin Once Daily Is as Effective as 10-Day Clarithromycin Twice Daily for the Treatment of Acute Exacerbations of Chronic Bronchitis and Is Associated With Reduced Health-Care Resource Utilization.
128:1980-1988.
2005
-
Glycopyrrolate Causes Prolonged Bronchoprotection and Bronchodilatation in Patients With Asthma.
128:1974-1979.
2005
-
Warfarin maintenance dosing patterns in clinical practice - Implications for safer anticoagulation in the elderly population.
127:2049-2056.
2005
-
Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study..
127:1857-1861.
2005
-
Lung volume reduction surgery vs medical treatment: for patients with advanced emphysema..
127:1166-1177.
2005
-
Asthma in remission: can relapse in early adulthood be predicted at 18 years of age?.
127:845-850.
2005
-
New Approaches to the Diagnosis of Heparin-Induced Thrombocytopenia.
127:35S-45S.
2005
-
The Pathophysiology of Heparin-Induced Thrombocytopenia.
127:9S-20S.
2005
-
Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines.
127:335-371.
2005
-
Antithrombotic Therapy During Percutaneous Coronary Intervention.
126:576S-599S.
2004
-
Antithrombotic Therapy in Children*.
126:645S-687S.
2004
-
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts.
126:600S-608S.
2004
-
Antithrombotic and Thrombolytic Therapy: From Evidence to Application.
126:688S-696S.
2004
-
Applying the Grades of Recommendation for Antithrombotic and Thrombolytic Therapy.
126:179S-187S.
2004
-
Hemorrhagic Complications of Anticoagulant Treatment.
126:287S-310S.
2004
-
Heparin and Low-Molecular-Weight Heparin.
126:188S-203S.
2004
-
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention.
126:311S-337S.
2004
-
Methodology for Guideline Development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy.
126:174S-178S.
2004
-
New Anticoagulant Drugs.
126:265S-286S.
2004
-
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects.
126:234S-264S.
2004
-
The Pharmacology and Management of the Vitamin K Antagonists.
126:204S-233S.
2004
-
The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
126:172S-173S.
2004
-
Use of Antithrombotic Agents During Pregnancy.
126:627S-644S.
2004
-
High-frequency oscillatory ventilation in adults: the Toronto experience..
126:518-527.
2004
-
Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points.
126:501-508.
2004
-
Dosing Practices and Risk Factors for Bleeding in Patients Receiving Enoxaparin for the Treatment of an Acute Coronary Syndrome.
125:1616-1621.
2004
-
Geographic and Gender Variability in the Prevalence of Bronchial Responsiveness in Canada.
125:1657-1664.
2004
-
Guidelines for Empiric Antimicrobial Prescribing in Community-Acquired Pneumonia.
125:1888-1901.
2004
-
Measuring Health-Related Quality of Life in Adults During an Acute Asthma Exacerbation.
125:93-97.
2004
-
Advances and Contemporary Issues in Prophylaxis for Deep Vein Thrombosis.
124:347S-348S.
2003
-
Advances and contemporary issues in prophylaxis for deep vein thrombosis..
124:347S-348S.
2003
-
Controversies in Timing of the First Dose of Anticoagulant Prophylaxis Against Venous Thromboembolism After Major Orthopedic Surgery.
124:379S-385S.
2003
-
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery..
124:379S-385S.
2003
-
Duration of Venous Thromboembolism Prophylaxis After Surgery.
124:386S-392S.
2003
-
Duration of venous thromboembolism prophylaxis after surgery..
124:386S-392S.
2003
-
Temporal Trends in Prevention of Venous Thromboembolism Following Primary Total Hip or Knee Arthroplasty 1996–2001.
124:349S-356S.
2003
-
Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry..
124:349S-356S.
2003
-
A Comparison of the Original Chronic Respiratory Questionnaire With a Standardized Version.
124:1421-1429.
2003
-
Relation Between Lung Function and RBC Distribution Width in a Population-Based Study*.
124:494-500.
2003
-
A Meta-analysis of Nocturnal Noninvasive Positive Pressure Ventilation in Patients With Stable COPD.
124:337-343.
2003
-
Dying in the ICU: perspectives of family members..
124:392-397.
2003
-
Inhalation of a Dry Powder Tobramycin PulmoSphere Formulation in Healthy Volunteers.
124:360-366.
2003
-
Evaluation of a Practice Guideline for Noninvasive Positive-Pressure Ventilation for Acute Respiratory Failurea.
123:2062-2073.
2003
-
Short-term Noninvasive Pressure Support Ventilation Prevents ICU Admittance in Patients With Acute Cardiogenic Pulmonary Edemaa.
123:2057-2061.
2003
-
Airway hyperresponsiveness..
123:411S-416S.
2003
-
Fondaparinux Reduces Long-term Risk of Venous Thromboembolism After Surgery for Hip Fractur.
124:371S-371S.
2003
-
GI Complications After Lung Transplantation in Patients With Cystic Fibrosis.
123:37-41.
2003
-
Effects of Nebulized Diethylenetetraamine-NONOate in a Mouse Model of Acute Pseudomonas aeruginosa Pneumonia.
122:2127-2136.
2002
-
A Randomized Controlled Trial to Evaluate the Effect of Informing Patients About Their Pretreatment Responses to Two Respiratory Questionnaires.
122:1701-1708.
2002
-
Effect of air filtration systems on asthma: a systematic review of randomized trials..
122:1535-1542.
2002
-
Clinically Important Improvements in Asthma-Specific Quality of Life, But No Difference in Conventional Clinical Indexes in Patients Changed From Conventional Beclomethasone Dipropionate to Approximately Half the Dose of Extrafine Beclomethasone Dipropionate.
121:1824-1832.
2002
-
Safety of Pressure-Volume Curve Measurement in Acute Lung Injury and ARDS Using a Syringe Technique.
121:1595-1601.
2002
-
The Design of Randomized Clinical Trials in Critically Ill Patients.
121:1290-1300.
2002
-
MIASMA - Asthma exacerbation reduction with salmeterol - Reply.
121:1003-1004.
2002
-
Airway hyperresponsiveness and calcium handling by smooth muscle: a "deeper look"..
121:621-624.
2002
-
Introduction to a Series of Systematic Reviews of Weaning From Mechanical Ventilation.
120:396S-399S.
2001
-
Mechanical Ventilator Weaning Protocols Driven by Nonphysician Health-Care Professionals.
120:454S-463S.
2001
-
Predicting Success in Weaning From Mechanical Ventilation.
120:400S-424S.
2001
-
Qualitative Studies on the Patient's Experience of Weaning From Mechanical Ventilation.
120:469S-473S.
2001
-
Treatment of warfarin-associated coagulopathy: a physician survey..
120:1972-1976.
2001
-
Trials Comparing Alternative Weaning Modes and Discontinuation Assessments.
120:425S-437S.
2001
-
Trials Comparing Early vs Late Extubation Following Cardiovascular Surgery.
120:445S-453S.
2001
-
Trials of Corticosteroids to Prevent Postextubation Airway Complications.
120:464S-468S.
2001
-
Trials of Miscellaneous Interventions to Wean From Mechanical Ventilation.
120:438S-444.
2001
-
Differential Cell Counts in Sputum in Respiratory Epidemiology.
120:1107-1113.
2001
-
Home Oxygen Requalification.
120:318-319.
2001
-
Do Blood Transfusions Improve Outcomes Related to Mechanical Ventilation?.
119:1850-1857.
2001
-
Deleterious effects of inhaled beta-agonists - Short-acting and long-acting agents differ.
119:1297-1299.
2001
-
Complications of Percutaneous Tracheostomy.
119:1282-1283.
2001
-
Sleep in critically ill patients requiring mechanical ventilation (vol. 117, pg 809, 2000).
119:993-993.
2001
-
Marked Tachypnea in Siblings With Chronic Beryllium Disease due to Copper-Beryllium Alloy.
119:647-650.
2001
-
Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention.
119:321S-336S.
2001
-
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves.
119:220S-227S.
2001
-
Antithrombotic therapy in patients undergoing percutaneous coronary intervention.
119:321S-336S.
2001
-
Grades of Recommendation for Antithrombotic Agents.
119:3S-7S.
2001
-
Hemorrhagic Complications of Anticoagulant Treatment.
119:108S-121S.
2001
-
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety.
119:64S-94S.
2001
-
Managing Oral Anticoagulant Therapy.
119:22S-38S.
2001
-
Managing oral anticoagulant therapy..
119:22S-38S.
2001
-
New Anticoagulant Drugs.
119:95S-107S.
2001
-
New anticoagulant drugs.
119:95S-107S.
2001
-
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range.
119:8S-21S.
2001
-
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range..
119:8S-21S.
2001
-
Platelet-active drugs : the relationships among dose, effectiveness, and side effects..
119:39S-63S.
2001
-
The Sixth (2000) ACCP Guidelines for Antithrombotic Therapy for Prevention and Treatment of Thrombosis.
119:1S-2S.
2001
-
The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians..
119:1S-2S.
2001
-
Use of Antithrombotic Agents During Pregnancy.
119:122S-131S.
2001
-
Use of antithrombotic agents during pregnancy..
119:122S-131S.
2001
-
Appropriateness of Domiciliary Oxygen Delivery.
118:1303-1308.
2000
-
Incidence, Predictive Factors, and Prognostic Significance of Supraventricular Tachyarrhythmias in Congestive Heart Failure.
118:914-922.
2000
-
Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study..
118:656-664.
2000
-
Laser Resection of a Pedunculated Tracheal Adenoma.
118:262-265.
2000
-
Endotracheal Aspiration in the Diagnosis of Ventilator-Associated Pneumonia.
117:195S-197S.
2000
-
Long-term effects of outpatient rehabilitation of COPD: A randomized trial..
117:976-983.
2000
-
Sleep in Critically Ill Patients Requiring Mechanical Ventilation.
117:809-818.
2000
-
Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group..
116:1297-1303.
1999
-
Physician Preferences for Perioperative Anticoagulation in Patients With a Mechanical Heart Valve Who Are Undergoing Elective Noncardiac Surgery.
116:1240-1246.
1999
-
Heparin and low-molecular-weight heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety (vol 114, pg 495S, 1998).
115:1760-1760.
1999
-
A Randomized Controlled Trial on the Effect of Inhaled Corticosteroids on Airways Inflammation in Adult Cigarette Smokers.
115:1271-1277.
1999
-
Validation of a Standardized Version of the Asthma Quality of Life Questionnaire.
115:1265-1270.
1999
-
Clickhaler (a Novel Dry Powder Inhaler) Provides Similar Bronchodilation to Pressurized Metered-Dose Inhaler, Even at Low Flow Rates.
115:952-956.
1999
-
The Clinical Utility of Invasive Diagnostic Techniques in the Setting of Ventilator-Associated Pneumonia.
115:1076-1084.
1999
-
Hemoptysis due to MDI therapy in a patient with permanent tracheostomy: treatment with mask AeroChamber..
115:279-282.
1999
-
Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1.
114:1505-1508.
1998
-
Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty.
114:728S-741S.
1998
-
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves.
114:602S-610S.
1998
-
Antithrombotic therapy in patients undergoing coronary angioplasty.
114:728S-741S.
1998
-
Grades of Recommendation for Antithrombotic Agents.
114:441S-444S.
1998
-
Hemorrhagic Complications of Anticoagulant Treatment.
114:511S-523S.
1998
-
Heparin and Low-Molecular-Weight Heparin.
114:489S-510S.
1998
-
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety..
114:489S-510S.
1998
-
New Antithrombotic Agents.
114:715S-727S.
1998
-
New antithrombotic agents.
114:715S-727S.
1998
-
Oral Anticoagulants.
114:445S-469S.
1998
-
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range..
114:445S-469S.
1998
-
Platelet-active drugs: the relationships among dose, effectiveness, and side effects..
114:470S-488S.
1998
-
The Accuracy and Interobserver Agreement in Detecting the ‘Gallop Sounds’ by Cardiac Auscultation.
114:1283-1288.
1998
-
Use of Antithrombotic Agents During Pregnancy.
114:524S-530S.
1998
-
Use of antithrombotic agents during pregnancy..
114:524S-530S.
1998
-
Intratracheal Pulmonary Ventilation at Low Airway Pressures in a Ventilator-Induced Model of Acute Respiratory Failure Improves Lung Function and Survival.
114:1147-1157.
1998
-
The Effect of Positive Pressure Airway Support on Mortality and the Need for Intubation in Cardiogenic Pulmonary Edema.
114:1185-1192.
1998
-
Evidence for the Needs of Out-of-Hospital Thrombosis Prophylaxis.
114:113S-114S.
1998
-
Managing Cough as a Defense Mechanism and as a Symptom.
114:133S-181S.
1998
-
The Incidence of Symptomatic Venous Thromboembolism After Enoxaparin Prophylaxis in Lower Extremity Arthroplasty.
114:115S-118S.
1998
-
The timing of tracheotomy: a systematic review..
114:605-609.
1998
-
Is There Really A Controversy Surrounding the Effectiveness of Respiratory Rehabilitation in COPD?.
114:1-4.
1998
-
Is it 'Worthwhile' to continue treating patients with a prolonged stay (> 14 days) in the ICU? An economic evaluation.
114:192-198.
1998
-
A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group..
113:131-141.
1998
-
Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials..
113:165-171.
1998
-
Pneumonitis due to Mycobacterium avium complex in hot tub water - Infection or hypersensitivity?.
112:1713-1713.
1997
-
Treatment of Diffuse Tracheomalacia Secondary to Relapsing Polychondritis With Continuous Positive Airway Pressure.
112:1701-1704.
1997
-
Intratracheal Pulmonary Ventilation and Continuous Positive Airway Pressure in a Sheep Model of Severe Acute Respiratory Failure.
112:1060-1067.
1997
-
A New Index of Prognostic Severity for Chronic Asthma.
112:582-590.
1997
-
Economic Analysis of Respiratory Rehabilitation.
112:370-379.
1997
-
Adenovirus-mediated gene transfer of the proteoglycan biglycan induces fibroblastic responses in the lung..
111:137S.
1997
-
In vivo adenovirus-mediated expression of human pre-elafin, a potent neutrophil elastase inhibitor..
111:128S-129S.
1997
-
Pulmonary Vasculopathy and Recurrent Pneumothoraces.
111:1784-1784.
1997
-
Transient Gene Transfer and Expression in the Lung.
111:89S-94S.
1997
-
The components of a respiratory rehabilitation program: a systematic overview..
111:1077-1088.
1997
-
Leukotrienes in the Pathogenesis of Asthma.
111:27S-34S.
1997
-
Mycobacterium avium Complex Infection in an Immunocompetent Young Adult Related to Hot Tub Exposure.
111:242-245.
1997
-
Symptom Intensity and Subjective Limitation to Exercise in Patients With Cardiorespiratory Disorders.
110:1255-1263.
1996
-
Cardiovascular Safety of High Doses of Inhaled Fenoterol and Albuterol in Acute Severe Asthma.
110:595-603.
1996
-
Long-acting β-Agonists, Tachyphylaxis, and Corticosteroids.
109:862-864.
1996
-
Volume reduction surgery. How selective should we be?.
109:1129-1130.
1996
-
Metered-dose inhaler salbutamol-induced tracheal epithelial lesions in intubated rabbits. Effects of the site of administration and time..
108:1668-1672.
1995
-
Antithrombotic Therapy for Cerebrovascular Disorders.
108:444S-456S.
1995
-
Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty.
108:486S-501S.
1995
-
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves.
108:371S-379S.
1995
-
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts.
108:424S-430S.
1995
-
Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects..
108:247S-257S.
1995
-
Clinical Recommendations Using Levels of Evidence for Antithrombotic Agents.
108:227S-230S.
1995
-
Hemorrhagic Complications of Anticoagulant Treatment.
108:276S-290S.
1995
-
Hemorrhagic complications of anticoagulant treatment..
108:276S-290S.
1995
-
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism..
108:291S-301S.
1995
-
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety.
108:258S-275S.
1995
-
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety..
108:258S-275S.
1995
-
New Antithrombotics.
108:471S-485S.
1995
-
Oral Anticoagulants.
108:231S-246S.
1995
-
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range..
108:231S-246S.
1995
-
Prevention of Venous Thromboembolism.
108:312S-334S.
1995
-
Use of antithrombotic agents during pregnancy..
108:305S-311S.
1995
-
REGULAR BETA-ADRENERGIC AGONISTS.
108:590-590.
1995
-
The Effects of Posture Change and Continuous Positive Airway Pressure on Cardiac Natriuretic Peptides in Congestive Heart Failure.
107:909-915.
1995
-
Interobserver Variation in the Computed Tomographic Evaluation of Mediastinal Lymph Node Size in Patients With Potentially Resectable Lung Cancer.
107:116-119.
1995
-
HOSPITAL-BASED ASTHMA EDUCATION - ACHIEVING THE GOALS AND EVALUATING THE OUTCOME.
106:S237-S241.
1994
-
Hospital-based Asthma Education.
106:237S-241S.
1994
-
Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group..
106:718-724.
1994
-
Regular beta-adrenergic agonists. Evidence, not reassurance, is what is needed..
106:552-559.
1994
-
Dose-effect Relationship of the β-Agonists Fenoterol and Salbutamol in Patients With Asthma.
105:1738-1742.
1994
-
ORAL ANTICOAGULANTS.
105:1903-1903.
1994
-
Effect of Magnitude of Airway Responsiveness and Therapy With Inhaled Corticosteroid on Histamine Tachyphylaxis in Asthma.
105:1434-1438.
1994
-
Pulmonary Vascular Lesions in Chronic Thromboembolic Pulmonary Hypertension.
105:1619-1620.
1994
-
Selective decontamination of the digestive tract. An overview..
105:1221-1229.
1994
-
Rules of Evidence and Clinical Recommendations on the Use of Antithrombotic Agents.
105:647-647.
1994
-
Efficiency of bronchodilator aerosol delivery to the lungs from the metered dose inhaler in mechanically ventilated patients. A study comparing four different actuator devices..
105:214-218.
1994
-
Oral Anticoagulant Therapy Recommendations.
105:328-328.
1994
-
D-Dimer in Patients With Clinically Suspected Pulmonary Embolism.
104:1679-1684.
1993
-
β-Agonists and Bronchial Asthma.
104:652-653.
1993
-
A Placebo-controlled Dose-finding Study With Bambuterol in Elderly Patients With Asthma.
103:771-776.
1993
-
Dosing Efficiency and Particle-size Characteristics of Pressurized Metered-dose Inhaler Aerosols in Narrow Catheters.
103:920-924.
1993
-
Emergency department management of life-threatening asthma. Are nebulizers obsolete?.
103:661-663.
1993
-
Concurrent Catamenial Hemothorax and Hemopneumothorax.
103:646-648.
1993
-
Increased Inhaled Bronchodilator vs Increased Inhaled Corticosteroid in the Control of Moderate Asthma.
102:1709-1715.
1992
-
Antithrombotic Agents in Coronary Artery Disease.
102:456S-481S.
1992
-
Antithrombotic Therapy for Cerebrovascular Disorders.
102:529S-537S.
1992
-
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves.
102:445S-455S.
1992
-
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts Following Percutaneous Transluminal Coronary Angioplasty.
102:508S-515S.
1992
-
Antithrombotic therapy. Introduction..
102:303S-304S.
1992
-
Aspirin and Other Platelet-Active Drugs.
102:327S-336S.
1992
-
Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects..
102:327S-336S.
1992
-
Cardiac Output Determination during Progressive Exercise in Cystic Fibrosis.
102:1118-1123.
1992
-
Hemorrhagic Complications of Anticoagulant Treatment.
102:352S-363S.
1992
-
Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism.
102:364S-373S.
1992
-
Hemorrhagic complications of anticoagulant treatment..
102:352S-363S.
1992
-
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism..
102:364S-373S.
1992
-
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety.
102:337S-351S.
1992
-
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety..
102:337S-351S.
1992
-
Oral Anticoagulants.
102:312S-326S.
1992
-
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range..
102:312S-326S.
1992
-
Prevention of Venous Thromboembolism.
102:391S-407S.
1992
-
RULES OF EVIDENCE AND CLINICAL RECOMMENDATIONS ON THE USE OF ANTITHROMBOTIC AGENTS.
102:S305-S311.
1992
-
Rules of evidence and clinical recommendations on the use of antithrombotic agents..
102:305S-311S.
1992
-
Use of Antithrombotic Agents During Pregnancy.
102:385S-390S.
1992
-
Use of antithrombotic agents during pregnancy..
102:385S-390S.
1992
-
Ciliary Function, Cell Viability, and in Vitro Effect of Ribavirin on Nasal Epithelial Cells in Acute Rhinorrhea.
102:284-287.
1992
-
Nosocomial pneumonia and the role of gastric pH. A meta-analysis..
100:7-13.
1991
-
Randomized Trials to Assess the Long-term Effects of Therapies on Angiographic End Points.
99:1243-1247.
1991
-
Bolus, front-loaded, and accelerated thrombolytic infusions for myocardial infarction and pulmonary embolism..
99:128S-128S.
1991
-
Allergistis non Carborundum.
99:522-522.
1991
-
A Randomized Trial of a Single Bolus Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Acute Pulmonary Embolism.
98:1473-1479.
1990
-
Is Theophylline Obsolete?.
98:1-3.
1990
-
Management of asthma and chronic airflow limitation. Are methylxanthines obsolete?.
98:44-52.
1990
-
A NEW SHORT INFUSION DOSAGE REGIMEN OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASE.
97:S168-S171.
1990
-
A New Short Infusion Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Venous Thromboembolic Disease.
97:168S-171S.
1990
-
Tissue Plasminogen Activator (rt-PA) vs Heparin in Deep Vein Thrombosis.
97:172S-175S.
1990
-
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial..
97:172S-175S.
1990
-
Accuracy of Asthma Mortality in France.
97:508-509.
1990
-
Clinical Validity of a Normal Perfusion Lung Scan in Patients with Suspected Pulmonary Embolism.
97:23-26.
1990
-
Discharging of Asthma Patients.
96:953-954.
1989
-
The Cardiopulmonary and Renal Hemodynamic Effects of Norepinephrine in Canine Pulmonary Embolism.
95:1333-1337.
1989
-
Stump Neuroma Masquerading as Recurrent Malignancy on Chest Roentgenogram.
95:684-685.
1989
-
ASPIRIN AND OTHER PLATELET ACTIVE-DRUGS - RELATIONSHIP AMONG DOSE, EFFECTIVENESS, AND SIDE-EFFECTS.
95:S12-S18.
1989
-
Antithrombotic Agents in Coronary Artery Disease.
95:52S-72S.
1989
-
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects..
95:12S-18S.
1989
-
HEMORRHAGIC COMPLICATIONS OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL-INFARCTION AND VENOUS THROMBOEMBOLISM.
95:S88-S97.
1989
-
Hemorrhagic Complications of Long-term Anticoagulant Therapy.
95:26S-36S.
1989
-
Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism.
95:88S-97S.
1989
-
Hemorrhagic complications of long-term anticoagulant therapy..
95:26S-36S.
1989
-
Optimal Therapeutic Range for Oral Anticoagulants.
95:5S-11S.
1989
-
Optimal therapeutic range for oral anticoagulants..
95:5S-11S.
1989
-
Use of Anticoagulants during Pregnancy.
95:156S-160S.
1989
-
Use of anticoagulants during pregnancy..
95:156S-160S.
1989
-
International Trends in Asthma Mortality: 1970 to 1985.
94:914-918.
1988
-
Aspergillus terreus as a Cause of Invasive Pulmonary Aspergillosis.
94:889-891.
1988
-
Cardiovascular Effects of Smoking in Patients with Ischemic Heart Disease.
93:14-19.
1988
-
THE USE OF BETA-ADRENERGIC BLOCKING-AGENTS, IV NITRATES AND CALCIUM-CHANNEL BLOCKING-AGENTS FOLLOWING ACUTE MYOCARDIAL-INFARCTION.
93:S25-S28.
1988
-
The use of beta-adrenergic blocking agents, i.v. nitrates and calcium channel blocking agents following acute myocardial infarction..
93:25S-28S.
1988
-
Measurement of Cardiac Output by CO2 Rebreathing in Unsteady State Exercise.
92:777-782.
1987
-
A Controlled Trial of Ambroxol in Chronic Bronchitis.
92:618-620.
1987
-
Rigorous evaluation. Greater need than ever..
92:580-581.
1987
-
Aerosol Therapy: Nebulizer vs Metered Dose Inhaler.
91:799-800.
1987
-
Aerosol therapy of reversible airflow obstruction. Concepts and clinical applications.
91:58S-64.
1987
-
Aerosol therapy of reversible airflow obstruction. Concepts and clinical applications..
91:58S-64S.
1987
-
Airway Inflammation and Airway Hyperresponsiveness.
90:575-577.
1986
-
A Meta-analysis of the Studies of Dihydroergotamine plus Heparin in the Prophylaxis of Deep Vein Thrombosis.
89:396S-400S.
1986
-
Introduction.
89:369S-369S.
1986
-
Prophylaxis of Venous Thromboembolism.
89:374S-383S.
1986
-
Prophylaxis of venous thromboembolism. An overview..
89:374S-383S.
1986
-
TREATMENT OF VENOUS THROMBOEMBOLISM.
89:S426-S433.
1986
-
Treatment of Venous Thromboembolism.
89:426S-433S.
1986
-
Venous Thromboembolism.
89:370S-373S.
1986
-
Venous thromboembolism. Scope of the problem..
89:370S-373S.
1986
-
Optimal Use of MDIs.
89:469-469.
1986
-
"Therapeutic range" for oral anticoagulant therapy..
89:11S-15S.
1986
-
Antithrombotic agents in coronary artery disease..
89:54S-67S.
1986
-
Dose antiplatelet agents; the relationship among side effects, and antithrombotic effectiveness..
89:4S-10S.
1986
-
Hemorrhagic Complications of Long-term Anticoagulant Therapy.
89:16S-25S.
1986
-
Hemorrhagic complications of long-term anticoagulant therapy..
89:16S-25S.
1986
-
“Therapeutic Range” for Oral Anticoagulant Therapy.
89:11S-15S.
1986
-
Diagnostic Value of Ventilation-Perfusion Lung Scanning in Patients with Suspected Pulmonary Embolism.
88:819-828.
1985
-
Isoxsuprine and Pulmonary Edema.
88:643-644.
1985
-
Are active and passive smoking harmful? Determining causation..
88:445-451.
1985
-
The Objective Measurement of Breathlessness.
88:84S-90S.
1985
-
Proper Use of Metered Dose Inhalers.
88:159-159.
1985
-
Advances in the Use of Inhalation Provocation Tests in Clinical Evaluation.
87:32S-35S.
1985
-
Clinical Evaluation of a Simple Demand Inhalation MDI Aerosol Delivery Device.
84:36-41.
1983
-
Alpha-adrenoceptors, adrenaline, and exaggerated vasoconstrictor response to stress in essential hypertension..
83:304-306.
1983
-
ALPHA-ADRENOCEPTORS, ADRENALINE, AND EXAGGERATED VASOCONSTRICTOR RESPONSE TO STRESS IN ESSENTIAL-HYPERTENSION.
83:304-306.
1983
-
UFFI Dust.
82:511-511.
1982
-
Principles of Aerosol Therapy.
82:39S-39S.
1982
-
Principles of aerosol therapy..
82:39S-41S.
1982
-
Aerosol penetration into the lung; influence on airway responses..
80:834-836.
1981
-
Optimal delivery of aerosols from metered dose inhalers..
80:911-915.
1981
-
The dyskinetic cilia syndrome; abnormal ciliary motility in association with abnormal ciliary ultrastructure..
80:860-865.
1981
-
The preferential deposition of inhaled isoproterenol and propranolol in asthmatic patients.
80:904-907.
1981
-
The preferential deposition of inhaled isoproterenol and propranolol in asthmatic patients..
80:904-907.
1981
-
AEROSOL PENETRATION INTO THE LUNG - INFLUENCE ON AIRWAY RESPONSES.
80:834-836.
1981
-
OPTIMAL DELIVERY OF AEROSOLS FROM METERED DOSE INHALERS.
80:911-915.
1981
-
THE DYSKINETIC CILIA SYNDROME - ABNORMAL CILIARY MOTILITY IN ASSOCIATION WITH ABNORMAL CILIARY ULTRASTRUCTURE.
80:860-864.
1981
-
What's in Exercise?.
78:678-679.
1980
-
The dyskinetic cilia syndrome. Ciliary motility in immotile cilia syndrome..
78:580-582.
1980
-
Thoracoscopy. A safe, accurate diagnostic procedure using the rigid thoracoscope and local anesthesia..
75:45-50.
1979
-
Site of beta-adrenergic receptors in the respiratory tract: use of fenoterol administered by two methods..
74:256-256.
1978
-
Cerebral dye embolus: a complication of selective bronchography following transbronchial biopsy..
73:872-873.
1978
-
Deposition and fate of aerosolized drugs..
73:936-943.
1978
-
Dose response and asthmatic patients to inhaled fenoterol..
73:990-991.
1978
-
Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects..
73:501-506.
1978
-
Measurements of Cardiac Output in Seriously Ill Patients Using a CO2 Rebreathing Method.
73:167-172.
1978
-
DEPOSITION AND FATE OF AEROSOLIZED DRUGS.
73:936-943.
1978
-
DOSE-RESPONSE OF ASTHMATIC-PATIENTS TO INHALED FENOTEROL.
73:990-991.
1978
-
Use of exercise in testing respiratory control mechanisms..
70:169-173.
1976
-
Restoration of Regional Wall Motion by Nitroglycerin Therapy in Patients with Left Ventricular Asynergy.
66:545-548.
1974
-
Suction Excision Biopsy for Diffuse Pulmonary Disease.
63:707-712.
1973
-
Regional Aerosol Clearance in Smokers and Nonsmokers.
59:2S-2S.
1971
-
Pleural Solitary Fibrous Stromal Tumor: Beware of the Elevated Hemidiaphragm
2016
-
GOLD Stage and Treatment in COPD: A 500 Patient Point Prevalence Study
2015
-
Low Prevalence of High Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening Study
2015
-
Assessment of the New Thin Convex Probe Endobronchial Ultrasound Scope: A Preliminary Study in the Porcine Lung
2013
-
Weaning Dobutamine in a Patient With Severe Cardiogenic Shock Using Hemodynamic Transesophageal Echocardiography
2013
-
A single dose of MEDI-528, a monoclonal antibody against interleukin-9, is well tolerated in mild and moderate asthmatics in the phase II trial MI-CP-138
2007
-
A RANDOMIZED TRIAL OF STRATEGIES FOR ASSESSING ELIGIBILITY FOR LONG-TERM DOMICILIARY OXYGEN THERAPY
2005
-
Do restrictive reimbursement processes inhibit physicians from adopting and implementing guidelines into their practice: The Canadian asthma experience
2005
-
FACTORS AFFECTING SUCCESSFUL TRANSITION FROM HIGH FREQUENCY OSCILLATION TO CONVENTIONAL MECHANICAL VENTILATION IN ADULT PATIENTS
2005
-
LONG PENTRAXIN 3, A NEW INFLAMMATORY MEDIATOR IN ACUTE LUNG INJURY
2005
-
LUNG DEPOSITION OF QVAR (HFA134A-BDP) IN NEWBORN INFANTS WITH BRONCHOPULMONARY DYSPLASIA (BPD)
2005
-
RISK PROFILES AND PROPHYLAXIS HISTORY OF PATIENTS DEVELOPING VENOUS THROMBOEMBOLISM IN THE OUTPATIENT SETTING: THE WORCESTER VENOUS THROMBOEMBOLISM STUDY
2005
-
Resistance phenotypes of Streptococcus pneumoniae and clinical outcome of respiratory tract infections treated with gemifloxacin
2005
-
THE CHANGING LANDSCAPE OF VENOUS THROMBOEMBOLISM: THE WORCESTER VENOUS THROMBOEMBOLISM STUDY
2005
-
The 2005 asthma action study in Canada
2005
-
An overview of the efficacy of gemifloxacin for the treatment of community-acquired pneumonia (CAP)
2004
-
Early vs delayed initiation of fondaparinux prophylaxis to prevent postoperative pulmonary embolism: A clinical endpoint study
2004
-
Improved Aerosolization of Suspensions Using Electronic Micropump Technology Compared to Conventional Pneumatic Nebulization
2004
-
Safety and Tolerability of Gemifloxacin: A Review of Clinical Trial Data
2004
-
Safety and efficacy of gemifloxacin compared to high dose amoxicilliniclavulanat e for the treatment of community-acquired pneumonia (CAP) of suspected pneumococcal origin
2004
-
The Efficacy of 5-Day Gemifloxacin Once Daily for the Treatment of Acute Exacerbations of Chronic Bronchitis (AECB)
2004
-
Airway Hyperresponsiveness
2003
-
Complement Inhibition Attenuates Human Lung Transplant Reperfusion Injury
1999
-
Adenovirus-Mediated Gene Transfer of the Proteoglycan Biglycan Induces Fibroblastic Responses in the Lung
1997
-
In Vivo Adenovirus-Mediated Expression of Human Pre-Elafin, a Potent Neutrophil Elastase Inhibitor
1997
-
The Clinical Efficacy of Combination Nebulized Anticholinergic and Adrenergic Bronchodilators vs Nebulized Adrenergic Bronchodilator Alone in Acute Asthma
1997
-
ANTITHROMBOTIC THERAPY IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
1995
-
Aspirin and Other Platelet-Active Drugs
1995
-
Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism
1995
-
NEW ANTITHROMBOTICS
1995
-
Use of Antithrombotic Agents During Pregnancy
1995
-
MORTALITY AMONG WORKERS WITH SILICOSIS IN ONTARIO
1987
-
DIAGNOSTIC-VALUE OF BAYESIAN-ANALYSIS FOR SUSPECTED PULMONARY-EMBOLISM IN PATIENTS WHO PRESENT A DIAGNOSTIC DILEMMA
1985
-
A PROSPECTIVE-STUDY OF VENTILATION-PERFUSION LUNG-SCANNING AND PULMONARY ANGIOGRAPHY IN PATIENTS WITH CLINICALLY SUSPECTED PULMONARY-EMBOLISM
1982
-
LUNG EPITHELIAL PERMEABILITY IN NORMAL SUBJECTS, ASTHMATICS AND SMOKERS
1982
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)